SA
SABS
SAB Biotherapeutics, Inc.
3.35
+3.72%
2026-10-30
52-week range
2.44
5.15
1-month+9.5%
3-month-11.6%
1-year+10.2%
3-year-64.7%
5-year-96.0%
vs 50-day+2.8%
vs 200-day-9.0%
Volatility61%
Beta1.05
$ vol/day$2M
ATH129.00
From ATH-97.4%
Next report2026-11-05
Nothing written about SABS yet.
Be the first — call it long or short with an entry we price for you,
or post a neutral write-up that takes no side.
Create a free account
2026AprJulOct
bought sold · bigger dot, bigger trade · follows the chart’s range
| When | People | Size | Value | Price | |
|---|---|---|---|---|---|
| 2.9y | buy | 1 | $1,531 | 8.59 | |
| 2.9y | buy | 2 | $14,290 | 9.32 | |
| 4.1y | buy | 1 | $7,300 | 7.27 | |
| 4.1y | buy | 1 | $10,360 | 6.76 | |
| 5.0y | sell | 1 | $2,196 | 96.41 |
Next report 2026-11-05 (Thursday, before open, in 5 days) · EPS estimate -0.27. It has finished the next session higher 47% of the time, average move 8.4%.
Day-after move, last 12 reports, oldest left.
| Reported | Est. | Actual | Surprise | Gap | Day 1 | Day 5 | |
|---|---|---|---|---|---|---|---|
| 2026-08-06 | miss | -0.28 | -0.28 | -1.0% | -0.3% | +2.1% | -0.5% |
| 2026-03-09 | miss | -0.17 | -0.41 | -142.1% | +5.5% | +6.8% | +6.0% |
| 2025-11-14 | beat | -0.46 | 0.50 | +209.1% | -2.3% | +4.5% | +27.4% |
| 2025-08-07 | miss | -0.80 | -1.09 | -36.9% | +2.1% | +1.8% | +0.9% |
| 2025-05-09 | beat | -1.07 | -0.56 | +47.8% | -2.7% | +4.1% | +7.6% |
| 2025-03-31 | beat | -1.21 | -0.98 | +18.9% | -0.3% | -8.1% | -25.0% |
| 2024-11-06 | miss | -1.09 | -1.12 | -2.6% | +0.0% | -17.2% | -6.3% |
| 2024-08-08 | beat | -1.15 | -0.79 | +31.1% | -4.1% | -12.9% | -10.5% |
| 2024-05-20 | miss | -0.98 | -1.14 | -15.9% | -13.0% | -15.7% | -18.3% |
| 2024-03-29 | miss | -0.64 | -6.39 | -898.7% | -0.7% | -5.5% | -1.8% |
| 2023-11-13 | beat | -1.15 | -1.01 | +12.4% | +0.0% | -2.2% | -5.2% |
| 2023-08-21 | beat | -1.45 | -1.29 | +10.8% | +9.1% | +3.8% | -20.1% |
| 2023-05-15 | miss | -1.00 | -1.48 | -47.6% | -1.1% | -11.4% | +0.8% |
| 2023-04-14 | miss | -1.15 | -1.81 | -57.2% | -0.8% | +6.1% | +1.5% |
| 2022-11-14 | miss | -1.10 | -1.83 | -66.0% | -0.8% | -15.2% | -13.6% |
| 2022-08-10 | miss | -1.00 | -1.50 | -50.5% | +1.7% | -2.6% | -3.5% |
| 2022-05-12 | miss | -1.10 | -1.35 | -22.8% | +3.4% | +11.2% | +7.3% |
| 2022-03-29 | miss | -0.75 | -3.40 | -352.8% | +2.2% | +15.6% | +17.8% |
| 2021-11-22 | miss | -0.60 | -1.20 | -100.0% | +0.9% | -13.1% | +13.5% |
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
-0.4%
Next 1 week
-2.0%
Next 1 month
+2.8%
Mean reversion
Deeply overbought — RSI(2) at 95
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought.
Its dip-buy edge in history is -1.34%/day.
Mean-reversion stats →
1-month breakdown —
Market · β 1.05 +2.6% · Seasonal tilt (4y) +0.1%
$2M/day volume
61% volatility
+10% 1-year
52-week range · 34% of the way up · -35% from the high
$2.44$5.15
Not investment advice.
Continue with Google